Sangamo Therapeutics
SGMO
#10631
Rank
โ‚น2.93 B
Marketcap
โ‚น7.09
Share price
0.00%
Change (1 day)
-87.88%
Change (1 year)

EPS for Sangamo Therapeutics (SGMO)

EPS in 2026 (TTM): -โ‚น33.98

According to Sangamo Therapeutics 's latest financial reports the company's current EPS (TTM) is -โ‚น36.40. In 2025 the company made an earnings per share (EPS) of -โ‚น42.15 an increase over its 2024 EPS that were of -โ‚น48.86.

EPS history for Sangamo Therapeutics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น33.98-19.38%
2025-โ‚น42.15-13.73%
2024-โ‚น48.86
2022-โ‚น119.750.81%
2021-โ‚น118.7933.33%
2020-โ‚น89.106.9%
2019-โ‚น83.3522.54%
2018-โ‚น68.021.43%
2017-โ‚น67.06-31.37%
2016-โ‚น97.7275.86%
2015-โ‚น55.5748.72%
2014-โ‚น37.36-17.02%
2013-โ‚น45.039.3%
2012-โ‚น41.19-39.44%
2011-โ‚น68.02

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น836.80-2,398.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,387-3,910.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น895.75-2,560.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-โ‚น382.25 950.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น710.85-2,052.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น342.48-1,040.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น363.09-1,097.37%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น134.12-468.42%๐Ÿ‡บ๐Ÿ‡ธ USA